chromogranin a stark erhöht
W… Bartolomucci A, Possenti R, Mahata SK, et al: The extended granin family: Structure, function, and biomedical implications. Boudreaux JP, Klimstra DS, Hassan MM, et al: The NANETS Consensus Guideline for the diagnosis and management of neuroendocrine tumors-Well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. 1. 2012:1-94. A Chromogranin A szintje a vérben általában alacsony, emelkedett szintje tünetekkel párosulva jele lehet neuroendokrin daganatnak. Neuroendocrine tumors (NETs) are characterized by having behavior and prognosis that depend upon tumor histology, primary site, staging, and proliferative index. The use of proton pump inhibitors and other acid-suppressive medications stimulate the growth of enterochromaffin cells to secrete CgA resulting in elevated levels of CgA in circulation. chromogranin can be quite variable and subject to diet, prescription drugs etc. Chromogranin A is elevated in pheochromocytomas. (8) Serial measurements may have some value in selected patients if the impaired renal function remains stable, in particular because CGA does not seem to change significantly following dialysis (in-house data, 24 patients; p=0.32). Caution should be kept in mind during the interpretation of chromogranin A as various factors can lead to false-positive as well as false-negative results. Granins are widespread in endocrine, neuroendocrine, peripheral, and central nervous tissues, where they are found in secretory granules alongside the tissue-specific secretion products. This possibility should be considered in patients who are evaluated or followed for neuroendocrine tumors and who show serum CGA elevations that are discordant to the clinical assessment or other biochemical and imaging tests. Chromogranin A (CGA) is a 439-amino acid protein with a molecular weight of 48 to 60 kDa, depending on glycosylation and phosphorylation status. In accordance with these Wndings, serum levels of chromogranin A were elevated (4 £ upper limit of normal) and the serum liver parameters were moderately elevated. The role of granins within the granules is to maintain the regulated secretion of these signaling molecules. This article does not provide medical advice. Protonenpumpenblocker). in. A clue to the etiology of the hyperchromogranin A was the elevated serum gastrin level leading to suspicion of proton pump inhibitor administration confirmed by admittance to its use. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366937/, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754364/, Arterial Switch Operation for Transposition of Great Arteries. In particular, when a tumor develops in an endocrine tissue, it becomes the main source of circulating CgA. © 1995–2021 Mayo Foundation for Medical Education and Research. 2011;32:755-797, 2. Guidelines recommend 3 to 12 monthly measurements of CGA or 5-HIAA in follow-up of midgut carcinoids. I am asked very frequently by patients and colleagues on interpretation of CGA. Suggests clinical disorders or settings where the test may be helpful, Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test. Chronic heart failure is also associated with increased levels of CgA and the levels are related to the intensity of heart failure. Im Serum kommt Chromogranin A mit einer Konzentration von unter 102 µg/l vor. Chromogranin A levels can be spuriously elevated with sitting up oppose to lying down, hypertension, strenuous activity, pregnancy, Interestingly, we seen often doubling of values prior to radiographic evidence of disease progression, suggesting that doubling of values maybe more prognostic for evaluating progression of disease where elevated levels are prognostic for disease. Pancreas. Tricoli JV, Schoenfeldt M, Conley BA: Detection of prostate cancer and predicting progression: Current and future diagnostic markers. Kullke MH, Benson AB, Bergsland E, et al: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines): NCCN Guidelines Version 1. Derfor kan der være betydelige forskelle på målinger fra forskellige laboratorier. Algeciras-Schimnich A, Preissner CM, Young WF, et al: Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytomas. In most cases, if none of these 3 analytes are elevated, carcinoids can usually be excluded as a cause of symptoms suggestive of carcinoid syndrome. Chromogranin A (chromogranin, CgA), a member of the chromogranin‐secretogranin family, was first discovered as an unidentified protein in perfusate of, and in granules isolated from the adrenal medulla where it is particularly abundant. As indicated in the Clinical Information, various non-neuroendocrine tumors might be associated with elevations, usually modest, in serum CGA concentrations. CGA Fragments Interfering with Accurate Quantification: Occasional patient specimens will contain mixtures of CGA fragments that lead to nonlinearity of measurement in specimens with high concentrations of CGA that need to be diluted. In addition, different CGA assays that use different antibodies or antibody combinations will display different cross-reactivity with the various CGA fragments. In-house data from 1760 specimens suggest that PPI elevate CGA level on average by 757 ng/mL, but a wide range of responses is observed, with some patients showing either lesser, or far greater elevations. J Clin Endocrinol Metab. There are currently no FDA-approved chromogranin A tests. Therefore, it is an accepted biomarker for the assessment of neuroendocrine tumors. Chromogranin-A Human Recombinant, His Tag PRO-699. 2008;93:91-95, 7. Adjunct in Diagnosis of Carcinoid Tumors: CGA is elevated in most patients (approximately 90%) with symptomatic or advanced carcinoids (carcinoid syndrome), usually to levels several times the upper limit of the reference interval. Therefore, the elevated concentration of chromogranin A is used as a marker of tumors in different diseases. Both chromogranin A and neurokinin A have been used as powerful prognostic indicators for midgut carcinoid tumors. Carcinoid Cancer. Bech PR, Ramachandran R, Dhillo WS, et al: Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript. (2), Non-neuroendocrine tumors that can lead to elevated levels of CgA include prostate cancer, ovarian cancer, breast cancer, colorectal cancer, pancreatic cancer, hepatocellular carcinoma, and hematological malignancies. 45 Chromogranin A Primary Antibodies: Thermo Fisher antibodies are validated for applications including western blotting, immunocytochemistry, flow cytometry, and chromatin immunoprecipitation. 1 CgA is physiologically released by exocytosis and may be detected in the blood. (2)eval(ez_write_tag([[250,250],'epainassist_com-banner-1','ezslot_4',149,'0','0']));eval(ez_write_tag([[250,250],'epainassist_com-banner-1','ezslot_5',149,'0','1'])); .banner-1-multi-149{border:none !important;display:block !important;float:none;line-height:0px;margin-bottom:15px !important;margin-left:0px !important;margin-right:0px !important;margin-top:15px !important;min-height:250px;min-width:250px;text-align:center !important;}, The neuroendocrine neoplasms, such as pheochromocytomas, parathyroid adenomas, medullary thyroid cancer, pituitary tumors (except prolactinomas), pulmonary neuroendocrine tumors including small cell lung cancer and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) secrete CgA. It has been identified as autoantigen in type 1 diabetes. PPIs lead to increased concentrations, about 5-10 times of CgA within 5 days of medication intake, which is seen in the early stages of neuroendocrine tumors. If they receive input from neurons, they are called neuroendocrine cells. In particular, proton pump inhibitors (PPI; eg, omeprazole), which are used in the treatment of esophageal and gastroduodenal ulcer disease and dyspepsia, will result in significant elevations of serum CGA levels, often to many times above the normal range. Over the past 2 decades, many studies reported and confirmed that CgA was a reliable diagnostic biomarker for NETs including gastroentero-pancreatic NETs (GEP-NET) [ 1 , 3 , 5 – 20 ] and also might be a prognostic … Drugs that stimulate secretion of neuroendocrine cells can lead to artifactual chromogranin A (CGA) elevations. Therefore, reference intervals and individual patient results differ significantly between different CGA assays and cannot be directly compared. Background. Chromogranin A (CgA) is a member of the granin family contained in secretory vescicles of chromaffin adrenal cells. Kromogranin A je polipeptid iz skupine granina koji se specifično stvara u neuroendokrinim tkivima zbog čega se vrlo uspješno koristi kao tumorski biljeg u dijagnostici neuroendokrinih tumora (karcinom pluća malih stanica, tumori probavnog trakta, tumor gušterače). Limited Agreement Among Different CGA Immunoassays: There is no universal calibration standard for serum CGA assays. On This Page Chromogranin A (CgA) Test: Overview Why it is recommended. The CLARINET trial evaluates the effects of lanreotide in patient… If absolutely necessary, H2-receptor antagonists at modest doses can be substituted for PPI in such patients without risking significant false-elevations in CGA.(7). The GEP-NETs that secrete CgA are associated with increased tumor burden and recurrence as well as a marker of poor prognosis and reduced survival in ileal and pancreatic neuroendocrine tumors. In this case, circulating chromogranin, serotonin, and urine 5-HIAA levels would not be elevated. The most common causes of non-neuroendocrine tumors (false-positive result) encountered in the clinical practice is the use of proton pump inhibitors (PPIs), atrophic gastritis cases and impaired kidney function. However, the kidneys can convert 5-HTP to serotonin, leading to high urine serotonin levels. T… Massironi S(1), Fraquelli M, Paggi S, Sangiovanni A, Conte D, Sciola V, Ciafardini C, Colombo M, Peracchi M. Author information: (1)Gastroenterology Unit II, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. As with all immunometric assays there is a low, but definite, possibility of false-positive results in patients with heterophile antibodies. PPI should therefore be discontinued for at least 2 weeks before CGA measurements, because the biological effects of PPI persist for a significant time period after the drugs are discontinued. It is significant in the diagnosis, prognosis, clinical evaluation after cytoreductive surgery, and follow up of these tumors. A kromogranin A (CgA) egy 49 kd molekulatömegű savas glikoprotein, melyet a neuroendokrin sejtek széles körben termelnek. However, if patients with advanced prostate cancer are found to have elevated CGA levels, this indicates the tumor contains a significant neuroendocrine cell subpopulation. Serum CGA and urine 5-hydroxyindolacetic acid (5-HIAA) are considered the most useful biochemical markers and are first-line tests in disease surveillance of most patients with carcinoid tumors. It is specifically used as a biomarker in oncology. Endocr Rev. In particular, CGA measurements might provide useful diagnostic information in patients with mild elevations in catecholamines and metanephrines;(6) such mild elevations often represent false-positive test results. A laboratóriumi vizsgálati eredmény tükrében a kezelőorvos további képalkotó vizsgálatokat rendel el a tumor helyének meghatározásához, majd ezt követően álltja fel a diagnózist. It can also serve as a sensitive means for detecting residual or recurrent disease in treated patients.(2-4). The most common causes of non-neuroendocrine tumors (false-positive result) encountered in the clinical practice is the use of proton pump inhibitors (PPIs), atrophic gastritis cases and impaired kidney function. Spurious False-Low Results Due to "Hook Effect": A "hook effect" can occur at extremely high CGA concentrations, resulting in a lower measured CGA concentration than is actually contained in the specimen. Chromogranin A Concentrated and Prediluted Cocktail Antibody 901-010-050819 Rev: 062117 Intended Use: For In Vitro Diagnostic Use Chromogranin A [LK2H10 + PHE5] is a mouse monoclonal antibody cocktail that is intended for laboratory use in the qualitative identification of chromogranin A protein by immunohistochemistry (IHC) in formalin- What is Dupuytren’s Fasciectomy, How is it Done, Know its Complications and Recovery? Can You Go Home With A Tracheostomy & Is A Tracheostomy Better Than A Ventilator? 2012;58:941-943. Ved visse kræftformer er koncentrationen af chromogranin A i blodet forhøjet. Chromogranin A (CgA) is a protein secreted by certain hormone-producing cells, called the neuroendocrine cells. “Chromogranin A is an excellent marker for neuroendocrine tumors, particularly nonfunctioning tumors, and measurement of chromogranin A is also useful to detect prostatic carcinoma in patients whose prostate specific antigen is not elevated.” Chromogranin A in blood–a useful tumor marker Syversen U, Heide LS, Waldum HL The sensitivity and specificity of CgA for various neuroendocrine tumors range from 60-100% and 70-100%, respectively, and the highest value is observed for serotonin-secreting neuroendocrine tumors (carcinoid tumors). However, if there is a strong clinical suspicion of hooking, then retesting after further sample dilution should be requested. CGA is a protein. ( krō'mō-gran'in ), A soluble and secretory hormone proteins of chromaffin granules. Hindgut tumors usually do not secrete serotonin and consequently, only CGA monitoring is recommended.(1-4). In every case, we found that PPI caused additional CGA elevations. Clin Cancer Res. This article may contains scientific references. Available at www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf, 5. A chromogranin A értéke emelkedett lehet pheochromocytomában, hasnyálmirigy, prosztata és … Neuroendocrine Tumors. Chromogranin A (CgA) is a 46-kDa glycoprotein, member of the granin family, exists within all type of neurons, normal neuroendocrine cells and is expressed in NET cells [7, 8]. (2)eval(ez_write_tag([[580,400],'epainassist_com-large-leaderboard-2','ezslot_3',151,'0','0'])); This article contains incorrect information. Unfortunately, it is also one of the trickiest tests to interpret. The antibodies were raised against a purified fragment containing amino acid sequence 116-439 in the chromogranin A molecule and it has been shown to measure both intact chromogranin A and fragments of chromogranin A (Stridsberg, M. et al. 2010;39:767-774, 4. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. Because of the linear relationship of CGA to tumor burden, its measurement also provides prognostic information. The elevated levels of CgA in prostate cancer are related to progression, poor prognosis and resistance to hormonal therapy. sara.massironi@libero.it (1)eval(ez_write_tag([[250,250],'epainassist_com-medrectangle-3','ezslot_6',173,'0','0']));eval(ez_write_tag([[250,250],'epainassist_com-medrectangle-3','ezslot_7',173,'0','1'])); .medrectangle-3-multi-173{border:none !important;display:block !important;float:none;line-height:0px;margin-bottom:15px !important;margin-left:0px !important;margin-right:0px !important;margin-top:15px !important;min-height:250px;min-width:250px;text-align:center !important;}, There are various causes of elevated chromogranin A (CgA) levels that are unrelated to neuroendocrine tumors. (1-4) Carcinoid tumors are subdivided into foregut carcinoids, arising from respiratory tract, stomach, pancreas or duodenum (approximately 15% of cases); midgut carcinoids, occurring within jejunum, ileum, or appendix (approximately 70% of cases); and hindgut carcinoids, which are found in the colon or rectum (approximately 15% of cases). The use of PPI also compounds the effects of other conditions, listed below, that can result in false-elevations of CGA. Histamine type-1 receptor antagonists are also related to increasing in CgA levels. 2011;32:1173-1175, 8. Chromogranin A (CgA) is an acidic glycoprotein with a molecular mass of 49 kd that is widely expressed by neuroendocrine cells and constitutes one of the most abundant components of secretory granules. However, test results that do not fit the clinical picture should always be discussed with the laboratory. Provides information to assist in interpretation of the test results, Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances, Recommendations for in-depth reading of a clinical nature, Customized Instructions & Shipping Guides. Laboratóriumi módszer. 549 During pregnancy, chromogranin A is also expressed by the trophoblast, decidua, and fetal membranes, and maternal serum levels exhibit a progressive rise … These patients should be monitored particularly closely.(5). The symptoms associated with carcinoid syndrome and vasoactive intestinal peptide tumors are treated with octreotide acetate. Chromogranin A is particularly useful for diagnosing mid and hindgut carcinoid tumors, since they may not secrete serotonin and 5-HIAA. These possible causes for elevated CgA concentrations should be considered when interpreting test results. Blocking reagents have been added to this assay to minimize the likelihood of heterophile antibody interference. It might not be possible to provide an accurate result in some of these individuals. (2), Other causes of elevated levels of CgA include hypertension, inflammatory bowel diseases, irritable bowel syndrome, pancreatitis, chronic hepatitis, liver cirrhosis, systemic rheumatoid arthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease, Parkinson’s disease, steroid treatment, food intake or strenuous exercise before a test. CHROMOGRANIN A. Tweet. What To Expect After A Tracheostomy Is Removed? These cells secrete CGA. Chromogranin A fungiert als Vorläufer von verschiedenen Peptiden wie Vasostatin-1 oder Parastatin und moduliert die Bildung von sekretorischen Vesikeln. As is typical for tumor marker use in follow-up and surveillance, a 40% to 50% change in serum CGA concentrations should be considered potentially clinically significant in the absence of confounding factors (see Cautions). Chromogranin A er et protein, der findes i kroppen i de såkaldte neuroendokrine celler. In advanced tumors, morbidity and mortality relate as much, or more, to the biogenic amines and peptide hormones secreted, as to local and distant spread. Chromogranins A, an acidic glycoprotein, comprises about 50% of the total protein of the granule matrix. 3 Klinik. A peptide fragment of ChgA located in the Vasostatin-1, namely ChgA29-42 has been identified as the antigenic epitope recognized by diabetogenic BDC2.5 T … 2µg ($50) 10µg ($130) 1mg ($5200) Shipped with Ice Packs Add to Cart. Paperback $74.95 $24.95 Buy Now, Advertisement Kindle Version $8.99 Buy Now. Anthony LB, Stosberg JR, Klimstra DS, et al: The NANETS Consensus Guideline for the diagnosis and management of neuroendocrine tumors - Well-differentiated NETs of the distal colon and rectum. There are various causes of elevated chromogranin A (CgA) levels that are unrelated to neuroendocrine tumors. Serial measurements should be performed with the same assay or, if assays are changed, patients should have their baseline re-established. Eine Erhöhung von Chromogranin A im Serum kann verschiedene Ursachen haben. Urine 5-hydroxyindolacetic acid (5-HIAA) and serum chromogranin A (CGA) increase in proportion to carcinoid tumor burden. Atrophic gastritis and pernicious anemia also lead to false elevations in serum CGA levels, by the same mechanism as PPI; lack of feedback inhibition of gastrin production due to gastric achlorhydria. Plasma chromogranin A is the most sensitive of the basal markers for neuroendocrine tumors, but cannot replace other established measures when screening for early pancreatic involvement in MEN 1. The PROMID trial assesses the effect of octreotide LAR on the tumor growth in patients with well-differentiated metastatic midgut NETs. These antibodies are rarely found in the normal population, but are observed at increased rates in persons with autoimmune disease or after prior sensitization to rodent proteins (eg, patients who have received diagnostic or therapeutic mouse monoclonal antibodies or animal exposure) and in case of immune system activation, such as those found following an infection, in autoimmune disease, or in some cancer patients. The role of CGA measurement is not well defined in these tumors, with the possible exception of prognostic information in advanced prostate cancer.(5). It can be used both for immunohistochemical stains and as a serum marker 4.. Immunohistochemistry. One example is testicular cancer, which in the in-house study was associated with a mean CGA increase of 189 ng/mL. Chromogranin A is elevated to several times the upper limit of the reference range in 90% of patients with carcinoid syndrome. The sensitivity and specificity of chromogranin A in all of these conditions differ significantly that depends on various factors; therefore, its use is limited as an effective prognostic and predictive biomarker for a narrow spectrum of conditions and diseases. Br J Cancer. Our articles are resourced from reputable online pages. The CGA elevations are less pronounced than in carcinoid tumors, and measurement of specific tumor secretion products is considered of greater utility. However, even modest kidney impairment can elevate serum CGA, and end-stage kidney failure is associated with elevations (in-house data: mean 471 ng/mL) similar to those observed in patients on PPI, making single serum CGA measurements uninterpretable. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign haemorrhagic cyst. OBS Chromogranin Assays er ikke standardiserede. However, CGA measurements can occasionally aid in diagnosis of these tumors if specific hormone measurements are inconclusive. For some cases, additional tests such as urine serotonin measurement will be required. This is the case in particular with pheochromocytoma and neuroblastoma, where CGA levels may be substantially elevated and can, therefore, provide supplementary and confirmatory information to measurements of specific hormones. A chromogranin A koncentrációja korrelál a betegség aktivitásával és a tumor méretével, a stresszhatások nem befolyásolják. The effects of hepatic failure are relatively minor in the absence of hepatocellular carcinoma or fulminant liver failure. Clin Chem. Reference values were derived from 162 donors (68 [42%] male and 94 [58%] female), ages 21 to 79. However, lately, it has been associated with various other conditions, including both benign and malignant. CgA concentrations may be elevated in other conditions, such as liver disease, inflammatory bowel disease, renal insufficiency, and with stress. It is a member of the granin family of proteins and polypeptides. Kidney failure and reduced renal clearance also lead to elevated levels of CgA. Ha a vizsgálat a betegség nyomon követésére irányul, a csökkenő CgA szint a tumor … A CgA fiziológiás körülmények között exocitózis során szabadul fel, és a vérből kimutatható lehet. (2,3) Patients with foregut tumors can also be monitored with CGA or 5-HIAA measurements, if they were positive for these markers at initial diagnosis. (2-4) Serum CGA measurements are used in conjunction with, or alternative to, measurements of serum or whole blood serotonin, urine serotonin and 5-HIAA, and imaging studies. It is a member of the granin family of proteins and polypeptides. (2). Eredmények értelmezése. However, results must be interpreted with extreme caution. The elevated levels of CgA cannot be used to assess the severity or progression of disease in non-neuroendocrine neoplasms as the tumor size does not correlate with tumor size or disease progression. Carcinoid tumors in particular almost always secrete CGA along with a variety of specific modified amines, chiefly serotonin (5-hydroxytryptamine: 5-HT) and peptides. Such tumors are often resistant to antiandrogen therapy and have a worse prognosis. Intervals are Mayo-derived, unless otherwise designated. A variety of … 1993, The decrease in CgA levels has also been used as a marker of response to treatment. A previous study in 148 pediatric patients (F=66, M=82; age range 1 day to 18 years) demonstrated that there is no significant difference in serum chromogranin A concentrations between children and adults. Opis. Pancreatic A, B and PP cells, gut argentaffin EC, argyrophil ECL and gastrin G cells, thyroid C cells, parathyroid cells, adrenal medullary cells, pituitary TSH, FSH and LH cells as well as some axons of visceral nerves have been found to react with chromogranin … To achieve maximum sensitivity in the initial diagnosis of suspected carcinoid tumors, serum CGA, serotonin in serum or blood, and 5-HIAA in urine should all be measured. It regulates the activity of endocrine, paracrine, and autocrine responses Cells that release hormones are called, endocrine cells. Kindle Version $34.95 $8.99 Buy Now Back to Top CHGA Human, Sf9 More Info Chromogranin A Human Recombinant, Sf9 PRO-2513. (2), CgA is the recommended first-line marker of GEP-NETs.